• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    DCAT Week ’19

    Temperature-Controlled Logistics

    Reducing Pill Burden

    Nasal Drug Delivery

    AI in Pharma: Transforming Data into Drugs
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    AGC, Calypso Form Devt./Mfg. Deal

    Quanticate Appoints SVP of Project Delivery

    Alkermes, Clovis Form Cancer Research Collaboration

    APC Expands to U.S. with Opening of MA Facility

    Evotec & HZI Parnter for Novel Antibiotics
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    ACG Capsules Expands in Brazil

    AGC, Calypso Form Devt./Mfg. Deal

    APC Expands to U.S. with Opening of MA Facility

    Catalent Enters Clinical Supply Partnership with Adial

    Catalent Receives P&G Award
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    ACG Capsules Expands in Brazil

    Catalent Receives P&G Award

    GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers

    Pelican BioThermal Opens New Network Location

    Reed-Lane Facility Tour
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Quanticate Appoints SVP of Project Delivery

    Alkermes, Clovis Form Cancer Research Collaboration

    APC Expands to U.S. with Opening of MA Facility

    Evotec & HZI Parnter for Novel Antibiotics

    Pii Inks Devt. Deal with Nemus
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Former FDA Senior Executives Join PAREXEL

    Top Global Pharma Company to Implement ValGenesis' VLMS

    WCG, Prudentia Enter Pharmacovigilance Alliance

    ValGenesis VLMS Chosen to Digitize Validation Process

    Serialization Compliance: Understanding the Challenges
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Alcami

    Vetter Pharma International GmbH

    Ascendia Pharmaceuticals

    Baxter BioPharma Solutions

    Federal Equipment Company
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Ascendia Pharmaceuticals

    Reed-Lane, Inc.

    Baxter BioPharma Solutions

    Jubilant HollisterStier Contract Manufacturing & Services

    Alcami
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
      • Top 20 Pharma & BioPharma
      • Top 10 BioPharma Companies
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Agenda
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Like the Temperature, It Feels Like Deal Activity is Heating Up

    A summary of 2016 transactions so far

    Related CONTENT
    • Clinical Trial Participants: Why So Elusive?
    • BioClinica Acquires Synowledge
    • Recap of Notable Recent CRO Transactions
    • BioClinica Launches eClinical CRO Partner Alliance Program
    • Chad Moore Joins LEERINK's Investment Banking Team
    Chad Moore, Leerink Partners LLC05.05.16
    While transaction activity in the Pharma Services sector has been steady the pace seems to have accelerated recently. Below is a summary of select announced or closed 2016 transactions. In addition, I provide thoughts on what the remainder of 2016 may hold for the sector.

    Select activity in 2016
    Similar to the overall market the beginning of 2016 was challenging for the stock prices of the publicly traded CROs. However, the public clinical stage CROs have outperformed the market. Over the last twelve months ending April 7, 2016, the market-cap weighted index of the publicly traded clinical CROs moved higher by approximately 7.5%. Over the same period the S&P 500 lost approximately 1.7%.

    inVentiv’s pending IPO—inVentiv Group Holdings, Inc. filed a Form S-1 with the SEC to potentially become a publicly traded company. The company’s private equity sponsor is Thomas H. Lee Partners.

    Precision for Medicine announced its intention to acquire ACT Oncology—ACT is a full-service oncology specialty CRO with particular experience conducting studies across all tumor types and hematology. Precision for Medicine refers to itself as the first dedicated Precision Medicine Research Organization.

    Charles River Labs acquired WIL Research—WIL is a leading provider of CDMO services to biopharma, agricultural and industrial chemical companies worldwide. Charles River said the acquisition enhances its “position as a leading global early-stage CRO by strengthening its ability to partner with global clients across the drug discovery and development continuum.”

    Medidata acquired Intelemage—Intelemage provides medical image sharing and workflow management solutions. Its solutions ease the sharing of medical file image sharing in clinical trials as well as for hospitals, physicians, life sciences companies, research institutions and core labs.

    LakePharma acquired BlueSky BioServices—The combination creates one of the largest, if not the largest, dedicated biologics CRO in the U.S. LakePharma is a provider of antibody development, protein expression and characterization, molecular biology and process development. BlueSky’s focus is bacterial and baculovirus systems, complementary molecular biology platforms and assay services. Together they provide end-to-end services for the biologics discovery research market.

    WIRB-Copernicus acquired Clintrax Global—Clintrax provides outsourced services for negotiating clinical trial-related contracts and budgets between sponsors, CROs and investigator sites as well as payments between these parties. By streamlining these functions and processes Clintrax can realize efficiencies and reduce study delays.
    Synexus acquired Research Across America (RAA)—The acquisition marks Synexus’s entry into the U.S. market. RAA is an independent site alliance where investigator sites are able to negotiate their own contracts and budgets and employ their own site coordinators and site managers.

    BioClinica acquired Clinverse—BioClinica continued is transaction activity by acquiring Clinverse. The target’s technology platform and solutions improve the efficiency of investigator and site payments by standardizing clinical trial-related financial transactions.

    Linden Capital acquired Chesapeake IRB and Compass IRB—In the span of a little over a month Linden acquired Chesapeake who then acquired Compass. Chesapeake is a cloud-based, paperless IRB with operations in the U.S. and Canada. The acquisition of Compass provides Chesapeake with additional accredited review professionals and geographic presence.

    Outlook for the Remainder of 2016
    Ongoing uncertainty with regard to the outcome of the U.S. presidential election cycle will continue to make healthcare-related headlines. As we approach November issues include the Affordable Care Act—will it remain or be repealed and replaced?; drug price scrutiny; and Medicare/Medicaid—overhaul, expand or trim?
    Sector specific issues include whether the biotech funding environment improves; continued growth of biologics/biosimilars; will RFP volume remain favorable; pharmaceutical sponsor M&A; backlog growth and burn rate; and foreign exchange rate fluctuations and its impact on earnings.

    Lastly, there are interesting and unique services/technologies in development by seasoned Pharma services executives that may significantly improve the speed and efficiency of clinical trials while enabling greater participation. More to come on this in the June issue.


    Chad Moore

    Chad Moore, CFA, is a Managing Director in Global Investment Banking at Leerink Partners LLC. He leads the firm’s Outsourced Pharmaceutical Services & IT Investment Banking effort. He can be reached at chad.moore@leerink.com or +1.703.216.7120. This article is not a product of Leerink Partners’ Research Department. It represents the opinion of the author and not necessarily that of Leerink Partners.
    Related Searches
    • Clinical Trials
    • biosimilars
    • end-to-end
    • Process Development
    Suggested For You
    Bioclinica Launches AGILE RTSM Bioclinica Launches AGILE RTSM
    Overcoming Preclinical Drug Development Hurdles Overcoming Preclinical Drug Development Hurdles
    Nimbus Therapeutics, Charles River in Strategic R&D Alliance Nimbus Therapeutics, Charles River in Strategic R&D Alliance
    Bioclinica, ArisGlobal Partner on Pharmacovigilance Services Bioclinica, ArisGlobal Partner on Pharmacovigilance Services
    LakePharma Acquires Blue Sky BioServices LakePharma Acquires Blue Sky BioServices
    Financial Report: Charles River Labs Financial Report: Charles River Labs
    Bioclinica Launches Post-Approval Research Division Bioclinica Launches Post-Approval Research Division
    Outsourced Pharma Services: 2015 Review & 2016 Outlook Outsourced Pharma Services: 2015 Review & 2016 Outlook
    Bioclinica Acquires Clinverse Bioclinica Acquires Clinverse
    Financial Report: Emergent BioSolutions Financial Report: Emergent BioSolutions
    Chad Moore Joins LEERINK Chad Moore Joins LEERINK's Investment Banking Team
    BioClinica Launches eClinical CRO Partner Alliance Program BioClinica Launches eClinical CRO Partner Alliance Program
    Recap of Notable Recent CRO Transactions Recap of Notable Recent CRO Transactions
    BioClinica Acquires Synowledge BioClinica Acquires Synowledge
    Clinical Trial Participants: Why So Elusive? Clinical Trial Participants: Why So Elusive?

    Related Columns

    • Biosimilars
      Know the Challenges of  Biosimilar Manufacturing

      Know the Challenges of Biosimilar Manufacturing

      Best practices for a competitive market
      Jerry Martin and Michiel Ultee 09.06.17

    • Biosimilars
      Indian Generic Firms  Expand Biosimilar Portfolios

      Indian Generic Firms Expand Biosimilar Portfolios

      With more players entering the ring, the race to enter the promising biosimilars market is getting hotter by the day in India
      S. Harachand, Contributing Editor 05.09.17

    • Biosimilars
      CMOs & Biosimilars Mfg. in the U.S.

      CMOs & Biosimilars Mfg. in the U.S.

      Biosimilars are moving from novel opportunity to mainstream product
      Eric S. Langer and Ronald A. Rader, BioPlan Associates 04.20.17


    • Biosimilars

      Biosimilars Update

      Fulfilling a dire need, but at what (human) cost?
      Ben Locwin, Contributing Editor 04.03.17

    • Drug Development | Drug Discovery

      The Trials and Tribulations of Male Contraception

      Where has research led in the search for effective oral male contraception?
      Adele Graham-King, Contributing Editor 03.07.17

    • Drug Development | Drug Discovery | R&D

      Taking the Wheeze Out of Asthma

      Novartis’ fevipiprant looks like a promising asthma treatment on the horizon
      Adele Graham-King, Contributing Editor 09.08.16


    • Biosimilars | Process Development

      Contract Manufacturing Budget Trends

      Study shows where the money is, and isn’t, flowing
      Eric S. Langer, BioPlan Associates 07.12.16

    • Clinical Trials | Process Development

      China Vaults to the Top of U.S. Biomanufacturers’ Off-Shoring Prospects

      A look at top destinations for future offshoring
      Eric S. Langer, BioPlan Associates 06.02.16

    • Clinical Trials

      Are More CRO Transactions Near?

      When will we see additional transactions involving the largest CROs?
      Chad Moore, Leerink Partners LLC 06.02.16


    • Drug Development | Drug Discovery

      How ‘Mush-room’ For Improvement in Antibiotic Production?

      The medical world is acutely aware of the issues on the horizon with regards to antibiotic resistance
      Adele Graham-King, Contributing Editor 06.02.16

    • Clinical Trials | Serialization | Supply Chain

      Anti-Counterfeiting in the Pharmaceutical Industry: An Evolution

      Keeping up with counterfeitors in the pharmaceutical industry is no easy task, but patients’ lives depend on it
      Ben Locwin, Healthcare Science Advisors 06.02.16

    • Analytical Services | Clinical Trials | Laboratory Testing | Supply Chain

      Analytical Instruments are On-Board with Outsourcing

      Newer process instruments are finally being designed with mobility in mind
      Emil W. Ciurczak, DoraMaxx Consulting 01.28.16

    • Biosimilars | Clinical Trials

      Outsourced Pharma Services: 2015 Review & 2016 Outlook

      A number of key themes and drivers are top of mind as 2016 kicks off. But first, I’ll briefly recap 2015, which was good to the publicly-traded pharma services outsourced providers. On average the group saw revenue grow, margins expand and,…
      Chad Moore, Leerink Partners 01.28.16

    • APIs | Biosimilars | Clinical Trials | Process Development | Vials

      2015 in Review: 6 Key Trends Affecting CMOs

      A look at major CMO trends ranging from budgets to growth opportunities
      Eric S. Langer, BioPlan Associates 11.17.15

    • APIs | Biosimilars

      API and Intermediate Outsourcing Trends

      One thing’s for sure, when it comes to pharma trends there is no definitive trend
      Ben Locwin, Healthcare Science Advisors 10.07.15

    Breaking News
    • AGC, Calypso Form Devt./Mfg. Deal
    • Quanticate Appoints SVP of Project Delivery
    • Alkermes, Clovis Form Cancer Research Collaboration
    • APC Expands to U.S. with Opening of MA Facility
    • Pii Inks Devt. Deal with Nemus
    View Breaking News >
    CURRENT ISSUE

    January/February 2019

    • DCAT Week ’19
    • Temperature-Controlled Logistics
    • Reducing Pill Burden
    • Nasal Drug Delivery
    • AI in Pharma: Transforming Data into Drugs
    • Digitization: Pharma 4.0
    • Serialization Compliance: Understanding the Challenges
    • FDA & Data Integrity
    • Rising Demand for Lyophilized Products
    • Future Trends in the CDMO Space
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • privacy policy
    • term and condition
    • about us
    • contact us

    follow us

    Subscribe

    magazines

    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login